From Casetext: Smarter Legal Research

Mylan Pharms. v. Acorda Therapeutics

Supreme Court of the United States
Jan 9, 2017
137 S. Ct. 625 (2017)

Opinion

No. 16–360.

01-09-2017

MYLAN PHARMACEUTICALS, et al., petitioners, v. ACORDA THERAPEUTICS, et al.


Petition for writ of certiorari to the United States Court of Appeals for the Federal Circuit denied.

Justice ALITO took no part in the consideration or decision of this petition.


Summaries of

Mylan Pharms. v. Acorda Therapeutics

Supreme Court of the United States
Jan 9, 2017
137 S. Ct. 625 (2017)
Case details for

Mylan Pharms. v. Acorda Therapeutics

Case Details

Full title:MYLAN PHARMACEUTICALS, et al., petitioners, v. ACORDA THERAPEUTICS, et al.

Court:Supreme Court of the United States

Date published: Jan 9, 2017

Citations

137 S. Ct. 625 (2017)
196 L. Ed. 2d 580

Citing Cases

Endo Pharms. Inc. v. Teva Pharms. USA, Inc.

Acorda Therapeutics Inc. v. Mylan Pharm. Inc., 817 F.3d 755, 760 (Fed. Cir. 2016) (citations omitted), cert.…